X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,115 | -68.4% | 27,628 | -43.7% | 0.00% | – |
| Q2 2023 | $95,157 | +14427.8% | 49,050 | +6413.9% | 0.00% | – |
| Q1 2023 | $655 | +54.5% | 753 | +76.3% | 0.00% | – |
| Q4 2022 | $424 | -57.6% | 427 | -26.3% | 0.00% | – |
| Q3 2022 | $1,000 | – | 579 | +242.6% | 0.00% | – |
| Q2 2022 | $0 | – | 169 | +19.0% | 0.00% | – |
| Q1 2022 | $0 | – | 142 | +13.6% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 125 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 125 | -5.3% | 0.00% | – |
| Q2 2021 | $1,000 | -97.9% | 132 | -97.6% | 0.00% | – |
| Q1 2021 | $48,000 | -72.4% | 5,579 | -79.5% | 0.00% | – |
| Q4 2020 | $174,000 | +95.5% | 27,156 | +105.0% | 0.00% | – |
| Q3 2020 | $89,000 | -45.4% | 13,244 | -24.0% | 0.00% | – |
| Q2 2020 | $163,000 | -32.6% | 17,419 | -27.8% | 0.00% | – |
| Q1 2020 | $242,000 | -4.0% | 24,136 | +2.6% | 0.00% | – |
| Q4 2019 | $252,000 | -13.7% | 23,534 | +2.6% | 0.00% | – |
| Q3 2019 | $292,000 | +71.8% | 22,935 | +102.5% | 0.00% | – |
| Q2 2019 | $170,000 | +2025.0% | 11,327 | +2456.9% | 0.00% | – |
| Q1 2019 | $8,000 | – | 443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |